Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TLR4 | O00206 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6913491 | 1.00 | CA1 (0.50) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL7064883 | 1.00 | CA1 (0.50) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL2690167 | 0.98 | KMT2A (0.52) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL20337323 | 0.98 | KMT2A (0.52) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL2690883 | 0.93 | — | — | |
| SCHEMBL17427855 | 0.93 | — | — | |
| SCHEMBL765417 | 0.93 | — | — | |
| SCHEMBL2693006 | 0.82 | — | — | |
| SCHEMBL12895014 | 0.82 | CA1 (0.46) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL10734273 | 0.82 | CA1 (0.46) | CA1CA2CA4KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751266-A | 4- (2-Butyl) amino aniline and preparation method thereof | 滁州市庆云医药有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-111513075-A | Microemulsion containing abamectin and indoxacarb and preparation method and application thereof | 河南波尔森农业科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| US-10562991-B2 | Developer, pattern forming method, and electronic device manufacturing method | FUJIFILM CORPORATION (JP) | 2020-02-18 | — | — | US | claimed |
| US-9290691-B2 | Organic el material-containing solution, method for forming organic el thin film, organic el device comprising organic el thin film, and method for manufacturing organic el display panel | IDEMITSU KOSAN CO., LTD. (JP) | 2016-03-22 | — | — | US | claimed |
| US-6280900-B1 | RADIATION SENSITIVE COMPOSITION WITH ALKALINE DEVELOPER SOLUBLE IN POLYMER COATED ON SUBSTRATE | JSR CORPORATION (JP) | 2001-08-28 | — | — | US | claimed |
| JP-5213863-A | — | — | None | — | — | JP | disclosed |
| CN-119751266-A | 4- (2-Butyl) amino aniline and preparation method thereof | 滁州市庆云医药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20250108023-A1 | Products for Masking Bitterness | The Third People's Hospital of Henan Province (CN) | 2025-04-03 | — | — | US | disclosed |
| CN-118108610-B | Preparation method of nortramadol hydrochloride | 山东新华制药股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-12048316-B2 | Sweetener and flavor compositions, methods of making and methods of use thereof | EPC NATURAL PRODUCTS CO., LTD. (CN) | 2024-07-30 | — | — | US | disclosed |
| CN-118108610-A | Preparation method of nortramadol hydrochloride | 山东新华制药股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11985994-B2 | Sweetener and flavor compositions, methods of making and methods of use thereof | EPC Natural Products Co., Ltd (CN) | 2024-05-21 | — | — | US | disclosed |
| US-4077700-A | Waveguide addressing and modulating method and apparatus | XEROX CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
| US-4005032-A | Liquid crystalline composition having mixed cholesteric-nematic properties | XEROX CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3989355-A | Electro-optic display system | XEROX CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
| US-3972588-A | Imaging method | XEROX CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3952193-A | Imaging method with U.V. excitation of liquid crystal | XEROX CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
| US-3947183-A | LIQUID CRYSTAL DISPLAY SYSTEM | XEROX CORPORATION (US) | 1976-03-30 | — | — | US | disclosed |
| US-3938880-A | Spherulitic liquid crystalline texture | XEROX CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
| US-3936640-A | Imaging system | XEROX CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |